Sequence-specific histone methylation is detectable on circulating nucleosomes in plasma

Clinical Chemistry

Volumn 54, Issue 7, 2008, Pages 1125-1131

  Deligezer, Ugur ^a   Akisik, Ebru E ^a   Erten, Nilgün ^b   Dalay, Nejat ^a,c  

^a Oncology Institute   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; LYSINE;

ALU SEQUENCE; ARTICLE; BLOOD CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; CIRCULATION; CLINICAL ARTICLE; CLINICAL CHEMISTRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; MULTIPLE MYELOMA; NUCLEOSOME; PLASMA; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN METHYLATION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE SPECIFIC HISTONE METHYLATION;

ALU ELEMENTS; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTONES; HUMANS; METHYLATION; MULTIPLE MYELOMA; NUCLEOSOMES; PLASMA; POLYMERASE CHAIN REACTION;

EID: 47549103707     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.101766     Document Type: Article

References (35)

1. Jenuwein T. The epigenetic magic of histone ly-sine methylation. FEBS J 2006;273:3121-35.
2. Khorasanizadeh S. The nucleosome: from genomic organization to genomic regulation. Cell 2004;116:259-72.
3. Jenuwein T, Allis CD. Translating the histone code. Science 2001;293:1074-80.
4. Strahl BD, Allis CD. The language of covalent histone modifications. Nature 2000;403:41-5.
5. Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005;15:163-76.
6. Lachner M, Jenuwein T. The many faces of histone lysine methylation. Curr Opin Cell Biol 2002; 14:286-98.
7. Rice JC, Allis CD. Code of silence. Nature 2001; 414:258-61.
8. Zhang K, Tang H, Huang L, Blankenship JW, Jones PR, Xiang F, et al. Identification of acet-ylation and methylation sites of histone H3 from chicken erythrocytes by high accuracy matrix-assisted laser desorption ionization-time-of-flight, matrix-assisted laser desorption ionization- postsource decay, and nanoelectrospray ionization tandem mass spectrometry. Anal Biochem 2002;306:259-69.
9. Zhang L, Eugeni EE, Parthun MR, Freitas MA. Identification of novel histone posttranslational modifications by peptide mass fingerprinting. Chromosoma 2003;112:77-86.
10. Grewal SI, Rice JC. Regulation of heterochromatin by histone methylation and small RNAs. Curr Opin Cell Biol 2004;16:230-8.
11. Peters AH, Kubicek S, Mechtler K, O'Sullivan RJ, Derijck AA, Perez-Burgos L, et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 2003;12:1577-89.
12. Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, et al. Histone methyl-transferases direct different degrees of methyl-ation to define distinct chromatin domains. Mol Cell 2003;12:1591-8.
13. Ozdag H, Teschendorff AE, Ahmed AA, Hyland SJ, Blenkiron C, Bobrow L, et al. Differential expression of selected histone modifier genes in human solid cancers. BMC Genomics 2006;7:90.
14. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids - a promising, noninvasive tool for early detection of several human diseases. FEBS Lett 2007;581:795-9.
15. Rago C, Huso DL, Diehl F, Karim B, Liu G, Papadopoulos N, et al. Serial assessment of human tumor burdens in mice by the analysis of circulating DNA. Cancer Res 2007;67:9364-70.
16. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology 2007;39:197-207.
17. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990;86:69-74.
18. Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, et al. Molecular characterization of circulating EBV-DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003;63:2028-32.
19. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002;48:1212-7.
20. Holdenrieder S, Stieber P, Bodenmueller H, Fertig G, Fü rst H, Schmeller N, et al. Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 2001;39:596-605.
21. Feinberg AP. An epigenetic approach to cancer etiology. Cancer J 2007;13:70-4.
22. Kondo Y, Issa JP. Enrichment for histone H3 lysine 9 methylation at Alu repeats in human cells. J Biol Chem 2003;278:27658-62.
23. Kondo Y, Shen L, Yan PS, Huang TH, Issa JP. Chromatin immunoprecipitation microarrays for identification of genes silenced by histone H3 lysine 9 methylation. Proc Natl Acad Sci U S A 2004;101:7398-403.
24. Martens JH, O'Sullivan RJ, Braunschweig U, Opravil S, Radolf M, Steinlein P, Jenuwein T. The profile of repeat-associated histone lysine meth-ylation states in the mouse epigenome. EMBO J 2005;24:800-12.
25. Deligezer U, Erten N, Akisik EE, Dalay N. Circulating fragmented nucleosomal DNA and caspase-3 mRNA in patients with lymphoma and myeloma. Exp Mol Pathol 2006;80:72-6.
26. Umetani N, Kim J, Hiramatsu S, Reber HA, Hines OJ, Bilchik AJ, Hoon DS. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 2006;52: 1062-9.
27. Holdenrieder S, Mueller S, Stieber P. Stability of nucleosomal DNA fragments in serum. Clin Chem 2005;51:1026-9.
28. Kondo Y, Shen L, Issa JP. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 2003;23:206-15.
29. Boggs BA, Cheung P, Heard E, Spector DL, Chinault AC, Allis CD. Differentially methylated forms of histone H3 show unique association patterns with inactive human X chromosomes. Nat Genet 2002;30:73-6.
30. Holdenrieder S, Stieber P, Chan LY, Geiger S, Kremer A, Nagel D, Lo YM. Cell-free DNA in serum and plasma: comparison of ELISA and quantitative PCR. Clin Chem 2005;51: 1544-6.
31. Amoura Z, Piette JC, Chabre H, Cacoub P, Papo T, Wechsler B, et al. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum 1997;40:2217-25.
32. Herman JG. Circulating methylated DNA. Ann N Y Acad Sci 2004;1022:33-9.
33. Swaminathan V, Reddy BA, Ruthrotha Selvi B, Sukanya MS, Kundu TK. Small molecule modulators in epigenetics: implications in gene expression and therapeutics. Subcell Biochem 2007;41: 397-428.
34. Huebert DJ, Kamal M, O'Donovan A, Bernstein BE. Genome-wide analysis of histone modifications by ChIP-on-chip. Methods 2006;40:365-9.
35. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006;24: 4270-6.